Co-delivery of IL17RB siRNA and doxorubicin by chitosan-based nanoparticles for enhanced anticancer efficacy in breast cancer cells-Reference-Cited by-同舟云学术

Co-delivery of IL17RB siRNA and doxorubicin by chitosan-based nanoparticles for enhanced anticancer efficacy in breast cancer cells

Published:2016-10 Issue: Volume:83 Page:229-240
ISSN:0753-3322
Container-title:Biomedicine & Pharmacotherapy
language:en
Short-container-title:Biomedicine & Pharmacotherapy

Author:

Alinejad Vahideh,Hossein Somi Mohammad,Baradaran Behzad,Akbarzadeh Parvin,Atyabi Fatemeh,Kazerooni Hanif,Samadi Kafil Hosein,Aghebati Maleki Leili,Siah Mansouri Homayoon,Yousefi Mehdi

Funder

Immunology Research Center

Publisher

Elsevier BV

Subject

Pharmacology,General Medicine

Reference40 articles.

1. Taking gene-expression profiling to the clinic: when will molecular signatures become relevant to patient care?;Sotiriou;Nat. Rev. Cancer,2007

2. Background risk of breast cancer influences the association between alcohol consumption and mammographic density;Trinh;Br. J. Cancer,2015

3. Enhanced antitumor activity of doxorubicin in breast cancer through the use of poly (butylcyanoacrylate) nanoparticles;Cabeza;Int. J. Nanomed.,2015

4. Inflammation and cancer;Coussens;Nature,2002

5. Interleukin-17 in fashion, at last: ten years after its description, its cellular source has been identified;Miossec;Arthritis Rheumatism,2007

Cited by 75 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Chitosan-based smart stimuli-responsive nanoparticles for gene delivery and gene therapy: Recent progresses on cancer therapy;International Journal of Biological Macromolecules;2024-10

2. Precision arrows: Navigating breast cancer with nanotechnology siRNA;International Journal of Pharmaceutics;2024-09

3. Chitosan nanoparticle applications in dentistry: a sustainable biopolymer;Frontiers in Chemistry;2024-04-10

4. Exploring the current landscape of chitosan-based hybrid nanoplatforms as cancer theragnostic;Carbohydrate Polymers;2024-02

5. Chitosan-functionalized bioplatforms and hydrogels in breast cancer: immunotherapy, phototherapy and clinical perspectives;Drug Discovery Today;2024-01